Document is current
Any future updates will be listed below
-
Authors
Jiang, Dan
Song, Zaiwei
Ma, Yi
Zhang, Xu
Bing, Hao
Xiong, Xin
Hu, Yang
Dong, Fei
Zhao, Rongsheng
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (72074005, 72304007)
Beijing Natural Science Foundation (7244474)
special fund of the National Clinical Key Specialty Construction Program, P.R.China (2023)
- License Information
-
More Information
Article History
Received: 16 October 2024
Revised: 4 December 2024
Accepted: 6 December 2024
First Online: 19 December 2024
Declarations
:
: This study was conducted according to the guidelines of the Declaration of Helsinki, and ethical approval was obtained from the Medical Ethics Committee of Peking University Third Hospital (No. IRB00006761-M2023451).
: The biological material used in this study consisted of blood samples collected from patients diagnosed with B-cell lymphoma. All samples were obtained with informed consent from participants, following the ethical guidelines and under the approval of the (Medical Ethics Committee, Peking University Third Hospital, and No. IRB00006761-M2023451).
: The authors declare no competing interests.
